- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.03. | Upperton Seeks MHRA Approval for New Sterile Manufacturing Facility | ||
| 05.03. | Therna Biosciences, Charles River Partner to Advance Single-Patient RNA Medicines | ||
| 05.03. | XyloCor Therapeutics Names New President and CEO | ||
| 04.03. | Codis Expands Mfg. Capabilities for Commercial-Scale Amorphous Solid Dispersions | ||
| 04.03. | Fujifilm Biotechnologies Introduces ShunzymeX Precision Purification Technology | ||
| 04.03. | Teva, Blackstone Life Sciences Enter $400M Funding Agreement for Duvakitug | ||
| 04.03. | Codexis Agrees to Manufacture 50 Grams of siRNA Using its Proprietary Manufacturing Platform | ||
| 04.03. | CordenPharma Colorado Leases Space at Flatiron Park Campus | ||
| 04.03. | Glenmark Gets FDA Nod for Fluticasone Propionate Inhalation Generic | ||
| 04.03. | Sino Biopharm Licenses Rovadicitinib to Sanofi for up to $1.5B | ||
| 04.03. | Antheia Secures Additional Funding from HHS to Onshore Supply Chains | ||
| 04.03. | Hoth Therapeutics Deploys OpenAI API to Support Development of HT-KIT | ||
| 04.03. | Moderna Resolves Worldwide Arbutus/Genevant Litigation | ||
| 03.03. | Latigo Biotherapeutics Names Neha Krishnamohan CFO and CBO | ||
| 03.03. | Kivu Bioscience Appoints Brunilda Shtylla Chief Business Officer | ||
| 03.03. | BostonGene, Unilever to Use Advanced AI, Multiomics to Explore Next-Gen Innovations | ||
| 03.03. | eXmoor Pharma Appoints Manuel Balbuena Chief Commercial Officer | ||
| 03.03. | Progeria Research Foundation, Forge Biologics Enter Gene Therapy Mfg. Pact | ||
| 03.03. | BioDuro Establishes Joint Venture with Cenra API Solutions | ||
| 03.03. | CellCarta Appoints Dr. Ehab A. El-Gabry as CMO and Head of Companion Diagnostics | ||
| 03.03. | Antiverse Raises $9.3M, Enters Research Pact with Cystic Fibrosis Foundation | ||
| 03.03. | ESTEVE CDMO Begins $15.5M Expansion of Chicago Small Molecule API Facility | ||
| 03.03. | Efor Acquires No Deviation | ||
| 03.03. | Sartorius Launches New Genetically Engineered CHO Host Cell Line | ||
| 03.03. | Novo Nordisk Announces $372.5M Expansion in Monksland, Athlone, Ireland |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.